Vaccination of pregnant women has been linked to a drop in newborns being admitted to hospital with a serious lung infection, research suggests.

BEYFORTUS is a prescription medicine used to help prevent a serious lung disease caused by Respiratory Syncytial Virus (RSV) in: Newborns and babies under 1 year of age born during or entering ...

Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing a phase 1 vaccine candidate to expand its RSV pipeline beyond mRNA.

BEYFORTUS® reduced hospital and doctor visits for RSV disease in babies by 87%, according to largest US real-world study ...

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, highlighting the need for targeted outreach programs.

Older adults hospitalized for respiratory syncytial virus (RSV) face an elevated risk of developing heart failure and a dangerous heart rhythm problem, a Canadian study found.

87% reduction in cases of respiratory syncytial virus (RSV) disease across all sites of care among healthy, term babies, born ahead of or during the RSV season98% reduction in hospitalizations of ...

This year’s flu season has been unusually severe – and COVID is still sending some people to hospital, too.

New UK data shows RSV vaccines in pregnant women cut infant hospitalizations by 72%, while premature babies are now protected with a new antibody shot offering immediate, 6-month immunity.

The Company hypothesized that NV-387 could be effective against Measles because NV-387 was previously found to completely cure RSV lung infection in a lethal animal model.

Looking for Clues Many lung cancers in nonsmokers have no known cause and are discovered only by chance. That was the case for Sandra Liu, 59, who lives in New Jersey. Ms.